Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
Open Access
- 1 January 2011
- journal article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 26 (1) , 68-75
Abstract
Park JS, et al. Korean J Intern Med. 2011 Mar;26(1):68-75. http://dx.doi.org/10.3904/kjim.2011.26.1.68Keywords
This publication has 15 references indexed in Scilit:
- Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparationsNephrology, 2006
- A Practical Citrate Anticoagulation Continuous Venovenous Hemodiafiltration Protocol for Metabolic Control and High Solute ClearanceClinical Journal of the American Society of Nephrology, 2006
- Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care systemJournal of Critical Care, 2005
- Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patientsKidney International, 2005
- Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT)Nephrology Dialysis Transplantation, 2005
- Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized studyIntensive Care Medicine, 2004
- Solute mass balance during isovolaemic high volume haemofiltrationIntensive Care Medicine, 2003
- Simplified citrate anticoagulation for continuous renal replacement therapyKidney International, 2001
- Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleedingKidney International, 1999
- Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patientsKidney International, 1990